Subsequently, an examination of The Cancer Genome Atlas database revealed a negative correlation between the efficacy of anti‐PD‐1 therapy and the expression levels of PD‐L1 and HRD1 in individuals with colon cancer. Here, SYVN1 is linked to malignant colon neoplasm.